Animas is now offering eligible, in-warranty Animas customers $750 to return their insulin pumps.


Use your rebate from Animas to offset the cost of a new t:slim X2™ insulin pump with Basal-IQ® technology through our Basal-IQ Technology Upgrade Program. Our pump access program gives you access to a new t:slim X2 pump for the remainder of your current pump warranty for a one-time payment of $999.

Terms and Conditions


t:slim X2 Insulin Pump with Basal-IQ Technology



Animas Pump Return Program

If you have an in-warranty Vibe or OneTouch Ping insulin pump, more information and registration details for the Animas Pump Return Program can be found here >> .




Get Started with a t:slim X2 Pump

Submit your information here to have someone reach out about our Basal-IQ Technology Upgrade Program.

The t:slim X2 insulin pump with Basal-IQ technology predicts and helps prevent lows with zero fingersticks.† Its touchscreen technology makes it simple to learn and simple to use, so whether you’re new to pump therapy or experienced, the t:slim X2 pump was designed for you.

* All fields are required.

By submitting this form, you grant Tandem Diabetes Care, Inc. permission to add your contact information to our database to send you information and communications related to our products. We respect and uphold the confidentiality of your personal information, and will not share your information with any third-parties, except as noted in our privacy policy. A link to our privacy policy is available at the bottom of this page.




Basal-IQ Technology Upgrade Program

t:slim X2 Insulin Pump Access Program for Non-Tandem Pump Users

If you are currently using a non-Tandem pump for your insulin therapy and are interested in upgrading to the t:slim X2 insulin pump with Basal-IQ technology, you have the option to use a new t:slim X2 pump for the remainder of your current pump warranty for a one-time payment of $999.

Terms and Conditions

Participants in this Basal-IQ Technology Upgrade Program (“Program”) must be able to cover the cost of supplies for the duration of their original pump’s existing warranty (“Program Period”), either through their current insurance plan or other standard payment options. Purchase of supplies directly from Tandem is not required. Supplies can continue to be purchased in most cases through the participant’s current distributor. Insurance verification, including confirmation of duration of the participant’s current pump warranty, and a prescription will be required to start the Program. Payment plans are not available

At the end of the Program Period, the t:slim X2 insulin pump with Basal-IQ technology must be returned to Tandem. Failure to return the pump within thirty (30) days following the end of the participant’s Program Period will result in a charge for the full cash price of the pump, less the prior $999 one-time payment.


Pricing terms and conditions for the Program are subject to change at any time, without notice. Limitations apply. This offer is not available for people under 6 years of age. Offer is not valid for: any person insured or subject to reimbursement in any part by Medicaid, Medicare, Tricare, or any other federal or state health programs (such as medical assistance programs); members of a Kaiser Permanente® Health Plan; members of United Healthcare plans that do not cover Tandem products, and any other health plans or insurance contracts that prohibit this Program; residents of any state where prohibited by law and persons residing outside the United States and Puerto Rico; or where otherwise prohibited.

Other exclusions may apply based on applicable private insurance programs. The Program is available only for current non-Tandem pump users who have at least six months remaining on the warranty of their current pump. Offer not available to individuals with in-warranty pumps who are eligible for a new pump through their insurance plan. The remaining warranty of a person’s existing pump will apply to the Tandem pump received through the Program. Warranty support for the Tandem pump during Program Period shall be in accordance with the warranty accompanying the product. This offer will expire December 31, 2019.




Responsible Use of
Basal-IQ Technology

Systems like the t:slim X2 insulin pump with Basal-IQ technology are not substitutes for active diabetes management, as there are common scenarios in which automated systems cannot prevent hypoglycemia. The Basal-IQ feature relies on continuous CGM readings and will not be able to predict glucose levels and suspend insulin delivery if your CGM is not working properly or is unable to communicate with your pump. Be sure to always use your pump, cartridges, CGM, and infusion sets as instructed and check them regularly to make sure they are working properly. Always pay attention to your symptoms, actively monitor your glucose levels, and treat according to your healthcare provider’s recommendations.


† If glucose alerts and CGM readings do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. 

Indications for Use

RX ONLY. The t:slim X2 Insulin Pump with Basal-IQ Technology (the System) consists of the t:slim X2 Insulin Pump, which contains Basal-IQ Technology, and a compatible CGM. CGM sold separately. The t:slim X2 Insulin Pump is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The t:slim X2 Insulin Pump can be used solely for continuous insulin delivery and as part of the System. When the System is used with a compatible iCGM, the Basal-IQ Technology can be used to suspend insulin delivery based on CGM sensor readings. Interpretation of the System results should be based on the trends and patterns seen with several sequential readings over time. CGM also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. Compatible iCGM systems are intended for single patient use and require a prescription. The System is indicated for use in individuals 6 years of age and greater. The System is intended for single patient use and requires a prescription. The System is indicated for use with NovoLog or Humalog U-100 insulin. The System is not approved for use in pregnant women, persons on dialysis, or critically ill patients.  

Important Safety Information >